2022
Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection
Lodi S, Klein M, Rauch A, Epstein R, Wittkop L, Logan R, Rentsch C, Justice A, Touloumi G, Berenguer J, Jarrin I, Egger M, Puoti M, Monforte A, Gill J, Ceron D, van Sighem A, Linas B, van der Valk M, Hernán M, Collaboration H. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co‐infection. Journal Of The International AIDS Society 2022, 25: e26048. PMID: 36562643, PMCID: PMC9784654, DOI: 10.1002/jia2.26048.Peer-Reviewed Original ResearchConceptsSustained virological responseHCV RNA testingDAA treatmentSVR ratesVirological responseProbability of SVRHepatitis C virus (HCV) cureRoutine HCV RNA testingActing antiviral (DAA) treatmentDAA treatment initiationCD4 cell countDirect antiviral agentsPresence of cirrhosisHCV RNA testEnd of treatmentClinical strataDAA recipientsHIV-HCVSVR assessmentSVR statusHIV acquisitionClinical characteristicsAntiviral treatmentTreatment initiationHCV genotypes
2012
HIV and Aging
High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. HIV and Aging. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2012, 60: s1-s18. PMID: 22688010, PMCID: PMC3413877, DOI: 10.1097/qai.0b013e31825a3668.Peer-Reviewed Original ResearchConceptsHIV risk behaviorsCurrent effective treatmentProgression of diseaseMedian life expectancyYears of ageMaintenance of functionAntiretroviral therapyHIV acquisitionHIV infectionImmune senescenceConcurrent diseasesEffective treatmentHIVHuman studiesRisk behaviorsFunctional measuresAIDS researchKey overarching themesLife expectancyNational InstituteTreatment effectsMultimorbidityAgeInfectionDisease